1997
Health after coronary stenting or balloon angioplasty: Results from the Stent Restenosis Study
Krumholz H, Cohen D, Williams C, Baim D, Brinker J, Cabin H, Heuser R, Hirshfeld J, Leon M, Moses J, Savage M, Cleman M. Health after coronary stenting or balloon angioplasty: Results from the Stent Restenosis Study. American Heart Journal 1997, 134: 337-344. PMID: 9327686, DOI: 10.1016/s0002-8703(97)70065-6.Peer-Reviewed Original ResearchConceptsStent Restenosis StudyCoronary stentingBalloon angioplastyRestenosis StudyDuke Activity Status IndexPalmaz-Schatz coronary stentingCanadian Cardiovascular Society classificationPalmaz-Schatz coronary stent implantationPercutaneous transluminal coronary angioplastyU.S. clinical sitesLong-term HRQoLForm Health SurveyHealth-related qualityMedical Outcomes StudyTransluminal coronary angioplastyCoronary stent implantationConventional balloon angioplastyDisease-specific measuresAngiographic restenosisConventional angioplastyIschemic eventsBodily painConsecutive patientsCoronary angioplastyCardiovascular perspective
1996
Economic assessment of platelet glycoprotein IIb/IIIa inhibition for prevention of ischemic complications of high-risk coronary angioplasty. EPIC Investigators.
Mark D, Talley J, Topol E, Bowman L, Lam L, Anderson K, Jollis J, Cleman M, Lee K, Aversano T, Untereker W, Davidson-Ray L, Califf R. Economic assessment of platelet glycoprotein IIb/IIIa inhibition for prevention of ischemic complications of high-risk coronary angioplasty. EPIC Investigators. Circulation 1996, 94: 629-35. PMID: 8772681, DOI: 10.1161/01.cir.94.4.629.Peer-Reviewed Original ResearchMeSH KeywordsAbciximabAgedAngioplastyAntibodies, MonoclonalAnticoagulantsAspirinBlood TransfusionCosts and Cost AnalysisDouble-Blind MethodFemaleHeparinHumansImmunoglobulin Fab FragmentsInfusions, IntravenousInjections, IntravenousMaleMiddle AgedMyocardial IschemiaPlatelet Aggregation InhibitorsPlatelet Glycoprotein GPIIb-IIIa ComplexRecurrenceStentsTreatment OutcomeUnited StatesConceptsHigh-risk coronary angioplastyC7E3 FabIschemic eventsCoronary angioplastyInitial hospitalizationPlatelet glycoprotein IIb/IIIa inhibitionGlycoprotein IIb/IIIa inhibitionIIb/IIIa inhibitionAggressive platelet inhibitionBaseline medical costsIschemic end pointsReduced ischemic eventsAcute ischemic eventsCost of therapyEPIC trialMajor bleedingBleeding episodesIschemic complicationsStandard carePlatelet inhibitionHospitalization ratesReceptor antibodiesHospital costsMedical costsMedicare fee
1995
Length of hospital stay and complications after percutaneous transluminal coronary angioplasty. Clinical and procedural predictors. Heparin Registry Investigators.
Wolfe M, Roubin G, Schweiger M, Isner J, Ferguson J, Cannon A, Cleman M, Cabin H, Leya F, Bonan R, Strony J, Adelman B, Bittl J. Length of hospital stay and complications after percutaneous transluminal coronary angioplasty. Clinical and procedural predictors. Heparin Registry Investigators. Circulation 1995, 92: 311-9. PMID: 7634443, DOI: 10.1161/01.cir.92.3.311.Peer-Reviewed Original ResearchConceptsPercutaneous transluminal coronary angioplastyLength of stayMultivessel coronary artery diseasePTCA complicationsCoronary artery diseaseTransluminal coronary angioplastyHospital stayUnstable anginaBaseline variablesAdvanced ageComplex lesionsArtery diseaseCoronary angioplastyLesion complexityNon-Q-wave myocardial infarctionIndividual baseline variablesBaseline risk factorsClinical risk scoreEmergency bypass surgeryProlonged hospital staySelection of patientsAbrupt vessel closureConventional balloon angioplastyAccess of patientsStrongest predictor1017-74 Length of Hospital Stay After Percutaneous Transluminal Coronary Angioplasty: Clinical and Angiographic Predictors
Bittl J, Wolfe M, Roubin G, Schweiger M, Isner J, Ferguson J, Cannon A, Cleman M, Cabin H, Leya F, Bonan R, Strony J, Adelman B, Investigators H. 1017-74 Length of Hospital Stay After Percutaneous Transluminal Coronary Angioplasty: Clinical and Angiographic Predictors. Journal Of The American College Of Cardiology 1995, 25: 392a. DOI: 10.1016/0735-1097(95)93083-o.Peer-Reviewed Original Research
1994
Predictors of Coronary Dissection following Percutaneous Transluminal Coronary Balloon Angioplasty
Ilia R, Bigham H, Brennan J, Cabin H, Cleman M, Remetz M. Predictors of Coronary Dissection following Percutaneous Transluminal Coronary Balloon Angioplasty. Cardiology 1994, 85: 229-234. PMID: 7987880, DOI: 10.1159/000176680.Peer-Reviewed Original ResearchConceptsCoronary dissectionLong lesionsPercutaneous transluminal coronary balloon angioplastyNon-Q-wave myocardial infarctionAcute coronary dissectionCoronary balloon angioplastyConsecutive patientsCoronary angioplastyBalloon dilatationFemale patientsArterial dilatationBalloon angioplastyMyocardial infarctionMost dissectionsPatientsMore dissectionAngioplastyDissectionLesionsComplicationsArteryDilatationPredictorsInfarctionWomen
1993
Myocardial risk area defined by technetium-99m sestamibi imaging during percutaneous transluminal coronary angioplasty: Comparison with coronary angiography
Haronian H, Remetz M, Sinusas A, Baron J, Miller H, Cleman M, Zaret B, Wackers F. Myocardial risk area defined by technetium-99m sestamibi imaging during percutaneous transluminal coronary angioplasty: Comparison with coronary angiography. Journal Of The American College Of Cardiology 1993, 22: 1033-1043. PMID: 8409038, DOI: 10.1016/0735-1097(93)90413-u.Peer-Reviewed Original ResearchMeSH KeywordsAdultAgedAged, 80 and overAngioplasty, Balloon, CoronaryClinical ProtocolsCollateral CirculationCoronary AngiographyCoronary DiseaseEvaluation Studies as TopicFemaleHumansMaleMiddle AgedMyocardial InfarctionObserver VariationPredictive Value of TestsPrognosisReproducibility of ResultsRisk FactorsSeverity of Illness IndexTechnetium Tc 99m SestamibiTomography, Emission-Computed, Single-PhotonConceptsMyocardial risk areaCoronary angiographyCoronary angioplastyQuantitative myocardial perfusionMyocardial perfusionMyocardial areaPercutaneous transluminal coronary angioplastyAngiographic risk scoresSmall risk areasTransluminal coronary angioplastyCoronary artery diseaseCoronary artery stenosisInitial myocardial uptakeAngioplasty balloon inflationArtery diseaseLeft anteriorNonperfused areaArtery stenosisCoronary anatomyCoronary arteryBalloon inflationPatient managementMyocardial uptakeRisk scoreAngioplastyClinical and Angiographic Determinants of Initial Percutaneous Transluminal Coronary Angioplasty Success
Ilia R, Kolanski D, Setaro J, Brennan J, Cabin H, Cleman M, Remetz M. Clinical and Angiographic Determinants of Initial Percutaneous Transluminal Coronary Angioplasty Success. Angiology 1993, 44: 677-682. PMID: 8357092, DOI: 10.1177/000331979304400901.Peer-Reviewed Original ResearchConceptsCoronary angioplastyPercutaneous transluminal coronary angioplastyTransluminal coronary angioplastyAcute myocardial infarctionSuccess rateDegree of stenosisLong-term pretreatmentAngiographic determinantsAngioplasty successPostinfarction anginaAngiographic characteristicsSuccessful angioplastyClinical featuresMyocardial infarctionAnatomic determinantsPrimary successAngioplastyPatientsSuccessful procedureAspirinBeneficial effectsLesionsHigh rateAdditional findingsAnginaCoronary angioplasty with gradual versus rapid balloon inflation: Initial results and complications
Ilia R, Cabin H, McConnell S, Cleman M, Remetz M. Coronary angioplasty with gradual versus rapid balloon inflation: Initial results and complications. Catheterization And Cardiovascular Interventions 1993, 29: 199-202. PMID: 8402842, DOI: 10.1002/ccd.1810290305.Peer-Reviewed Original ResearchConceptsInflation protocolFrequency of dissectionLesion morphological characteristicsRapid balloon inflationProcedure-related complicationsComplete success rateSuccess rateGradual inflationUnstable anginaComplication rateCoronary angioplastySignificant group differencesArterial damageBalloon inflationDissection rateHigh success rateDiseased vesselsMore lesionsPatientsLesionsInflation groupGroup differencesAngioplastyComplicationsVessel diameter ratio
1992
Restenosis after placement of Palmaz-Schatz stents in native coronary arteries. Initial results of a multicenter experience.
Ellis S, Savage M, Fischman D, Baim D, Leon M, Goldberg S, Hirshfeld J, Cleman M, Teirstein P, Walker C. Restenosis after placement of Palmaz-Schatz stents in native coronary arteries. Initial results of a multicenter experience. Circulation 1992, 86: 1836-1844. PMID: 1451256, DOI: 10.1161/01.cir.86.6.1836.Peer-Reviewed Original ResearchConceptsNative coronary arteriesIncidence of restenosisPalmaz-Schatz stentsHistory of restenosisCoronary arteryStent placementMultiple stentsSingle stentPoor long-term resultsQuantitative angiographic dataStandard coronary angioplastyExcellent angiographic resultsLong-term resultsSuccessful stent placementMultiple overlapping stentsPrior restenosisStent closureBaseline characteristicsMulticenter experienceConsecutive patientsCoronary angioplastySuch patientsAngiographic resultsOverall incidenceRandomized trialsCharacteristics of cigarette smokers versus nonsmokers in patients referred for coronary angioplasty
Ilia R, Brennan J, Cabin H, Cleman M, Remetz M. Characteristics of cigarette smokers versus nonsmokers in patients referred for coronary angioplasty. Coronary Artery Disease 1992, 3: 859-862. DOI: 10.1097/00019501-199209000-00013.Peer-Reviewed Original ResearchPercutaneous transluminal coronary angioplastyTransluminal coronary angioplastyCoronary angioplastyCoronary dissectionSuccess rateConsecutive patientsMajor complicationsCigarette smokersTotal occlusionLong lesionsAngioplastySmokersConsecutive lesionsPatientsLesionsNonsmokersDissectionComplicationsGroupOcclusionPercutaneous Transluminal Coronary Angioplasty in Unstable and Stable Angina pectoris: A Comparison of Immediate Success and Complications
Ilia R, Kolansky D, Setaro J, Brennan J, Cabin H, Cleman M, Remetz M. Percutaneous Transluminal Coronary Angioplasty in Unstable and Stable Angina pectoris: A Comparison of Immediate Success and Complications. Cardiology 1992, 81: 245-250. PMID: 1301250, DOI: 10.1159/000175811.Peer-Reviewed Original ResearchConceptsPercutaneous transluminal coronary angioplastyTransluminal coronary angioplastyStable angina pectorisUnstable angina pectorisAngina pectorisCoronary angioplastyMyocardial infarctionAcute Q-wave myocardial infarctionMore acute myocardial infarctionUrgent coronary artery bypassQ-wave myocardial infarctionUnstable angina groupCoronary artery bypassMajor complication ratePresence of thrombusAcute myocardial infarctionSuccess rateAngina groupArtery bypassStable anginaUnstable anginaComplication rateConsecutive patientsAdditional patientsCoronary thrombus
1991
Validation of continuous radionuclide left ventricular functioning monitoring in detecting silent myocardial ischemia during balloon angioplasty of the left anterior descending coronary artery
Kayden D, Remetz M, Cabin H, Deckelbaum L, Cleman M, Wackers F, Zaret B. Validation of continuous radionuclide left ventricular functioning monitoring in detecting silent myocardial ischemia during balloon angioplasty of the left anterior descending coronary artery. The American Journal Of Cardiology 1991, 67: 1339-1343. PMID: 2042565, DOI: 10.1016/0002-9149(91)90462-t.Peer-Reviewed Original ResearchConceptsSilent myocardial ischemiaLV ejection fractionLV dysfunctionMyocardial ischemiaEjection fractionLV functionBalloon inflationRelative end-systolic volumeTransient ST-segment depressionPercutaneous transluminal coronary angioplastyMean LV ejection fractionST-segment depressionContinuous electrocardiographic monitoringTransluminal coronary angioplastyLeft ventricular functionST-segment changesEnd-diastolic volumeEnd-systolic volumeIschemic decreaseCoronary angioplastyVentricular functionElectrocardiographic changesElectrocardiographic monitoringBalloon angioplastyCoronary arteryClinical experience with the Palmaz-Schatz coronary stent
Schatz R, Goldberg S, Leon M, Baim D, Hirshfeld J, Cleman M, Ellis S, Topol E. Clinical experience with the Palmaz-Schatz coronary stent. Journal Of The American College Of Cardiology 1991, 17: 155-159. PMID: 2016473, DOI: 10.1016/0735-1097(91)90952-6.Peer-Reviewed Original ResearchConceptsSingle stentPrior angioplastyAngiographic restenosisPalmaz-Schatz coronary stentHigher thrombosis rateUrgent bypass surgeryMajor bleeding eventsNative coronary arteriesBalloon-expandable stentsSuccessful elective stentingBleeding eventsBypass surgeryComplication rateDeath 3Elective stentingCoronary angioplastyCoronary stentingRoutine angioplastyThrombosis rateSubacute thrombosisAngioplasty resultsCoronary arteryMyocardial infarctionSubgroup analysisHigh incidenceClinical experience with the Palmaz-Schatz coronary stent. Initial results of a multicenter study.
Schatz R, Baim D, Leon M, Ellis S, Goldberg S, Hirshfeld J, Cleman M, Cabin H, Walker C, Stagg J. Clinical experience with the Palmaz-Schatz coronary stent. Initial results of a multicenter study. Circulation 1991, 83: 148-161. PMID: 1984878, DOI: 10.1161/01.cir.83.1.148.Peer-Reviewed Original ResearchConceptsUrgent bypass surgeryBypass surgeryPerioperative complicationsMyocardial infarctionGroup 2Group 1Palmaz-Schatz coronary stentSuccessful elective coronary angioplastyUnderwent cardiac catheterizationElective coronary angioplastyNative coronary arteriesAbsence of symptomsBalloon-expandable stentsClinical thrombosisPerioperative deathsElective angioplastyCardiac catheterizationCoronary angioplastyMajor complicationsMulticenter studyCoronary arteryPatient populationLower incidencePatientsAbrupt closure
1990
Reduction of myocardial ischemia during percutaneous transluminal coronary angioplasty with oxygenated Fluosol®11Fluosol® (20% Intravascular Perfluorochemical Emulsion) is a registered trademark of The Green Cross Corporation, Osaka, Japan.
Kent K, Cleman M, Cowley M, Forman M, Jaffe C, Kaplan M, King S, Krucoff M, Lassar T, McAuley B, Smith R, Wisdom C, Wohlgelernter D. Reduction of myocardial ischemia during percutaneous transluminal coronary angioplasty with oxygenated Fluosol®11Fluosol® (20% Intravascular Perfluorochemical Emulsion) is a registered trademark of The Green Cross Corporation, Osaka, Japan. The American Journal Of Cardiology 1990, 66: 279-284. PMID: 2195864, DOI: 10.1016/0002-9149(90)90836-p.Peer-Reviewed Original ResearchConceptsOxygen-carrying perfluorochemical emulsionFluosol perfusionAngioplasty patientsMyocardial ischemiaPerfluorochemical emulsionBaseline levelsGlobal left ventricular ejection fractionLeft ventricular ejection fractionPercutaneous transluminal coronary angioplastyRegional wall dysfunctionSevere anginal painTransluminal coronary angioplastyVentricular ejection fractionST-segment changesAnginal painGreen Cross CorporationCoronary angioplastyEjection fractionMulticenter trialRoutine angioplastyVentricular functionBalloon occlusionBalloon deflationPatient populationBalloon inflationMetabolic and functional effects of perfluorocarbon distal perfusion during coronary angioplasty
Young L, Jaffe C, Revkin J, McNulty P, Cleman M. Metabolic and functional effects of perfluorocarbon distal perfusion during coronary angioplasty. The American Journal Of Cardiology 1990, 65: 986-990. PMID: 2327360, DOI: 10.1016/0002-9149(90)91001-m.Peer-Reviewed Original ResearchConceptsGreat cardiac veinDistal perfusionLactate releaseEjection fractionVentricular functionCardiac veinBalloon inflationLeft ventricular ejection fractionDistal coronary perfusionMyocardial lactate metabolismVentricular ejection fractionMyocardial lactate releaseRegional contractile functionNet lactate extractionNet lactate releaseCoronary angioplastyLeft anteriorCoronary perfusionLactate extractionContractile functionPerfusionAngioplastyLactate concentrationLactate metabolismOxygenated perfluorocarbonMyocardial dysfunction during percutaneous transluminal coronary angioplasty.
Cleman M, Wohlgelernter D, Cabin H, Remetz M, McConnell S, Jaffe C. Myocardial dysfunction during percutaneous transluminal coronary angioplasty. Circulation 1990, 81: iv14-9. PMID: 2306846.Peer-Reviewed Original ResearchConceptsPercutaneous transluminal coronary angioplastyTransluminal coronary angioplastyBalloon inflationCoronary angioplastyEjection fractionMyocardial dysfunctionBrief balloon inflationBalloon inflation timeRegional myocardial dysfunctionRegional contractile dysfunctionTwo-dimensional echocardiographyRegional wall motionHemodynamic consequencesIschemic periodElectrocardiographic changesCardiac outputContractile dysfunctionProcedural resultsCoronary arteryPTCA proceduresTemporary ischemiaEchocardiographic recordingsVentricular myocardiumVentricular volumeInflation time
1989
Predictors of success in percutaneous transluminal coronary angioplasty of chronic total occlusions
LaVeau P, Remetz M, Cabin H, Hennecken J, McConnell S, Rosen R, Cleman M. Predictors of success in percutaneous transluminal coronary angioplasty of chronic total occlusions. The American Journal Of Cardiology 1989, 64: 1264-1269. PMID: 2589190, DOI: 10.1016/0002-9149(89)90565-1.Peer-Reviewed Original ResearchConceptsPercutaneous transluminal coronary angioplastyTransluminal coronary angioplastyChronic total occlusionTotal occlusionAngiographic variablesClinical durationCoronary angioplastySuccess rateUnderwent repeat percutaneous transluminal coronary angioplastyRepeat percutaneous transluminal coronary angioplastySuccessful percutaneous transluminal coronary angioplastyEmergency coronary artery bypassNon-Q-wave infarctionCoronary artery bypassAcute myocardial infarctionQ-wave infarctionClinical occlusionArtery bypassMean durationMyocardial infarctionDilatation sitePredictors of successLow success rateInfarctionPatients
1988
Myocardial Protection During Percutaneous Transluminal Coronary Angioplasty
Lasala J, Cleman M. Myocardial Protection During Percutaneous Transluminal Coronary Angioplasty. Cardiology Clinics 1988, 6: 329-343. PMID: 2977571, DOI: 10.1016/s0733-8651(18)30481-8.Peer-Reviewed Original ResearchUpdate on Percutaneous Transluminal Coronary Angioplasty
Cabin H, Cleman M. Update on Percutaneous Transluminal Coronary Angioplasty. Cardiology Clinics 1988, 6: 321-328. PMID: 2977570, DOI: 10.1016/s0733-8651(18)30480-6.Peer-Reviewed Original Research